Thyroid hormone receptor coactivators and corepressors

Thyroid

Volumn 8, Issue 8, 1998, Pages 703-713

  Koenig, Ronald J ^a,b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; DNA BINDING PROTEIN; LIOTHYRONINE; THYROID HORMONE RECEPTOR;

GENE ACTIVATION; GENE EXPRESSION REGULATION; GENE REPRESSION; HORMONAL REGULATION; HUMAN; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA INTERACTION; REVIEW; TRANSCRIPTION REGULATION;

EID: 0031783485     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.1998.8.703     Document Type: Review

References (105)

1. Sap J, Munoz A, Damm K, Goldberg Y, Ghysdael J, Leutz A, Beug H, Vennstrom B 1986 The c-erb-A protein is a high-affinity receptor for thyroid hormone. Nature 324:635-640.
2. Weinberger C, Thompson CC, Ong ES, Lebo R, Gruol DJ, Evans RM 1986 The c-erbA. gene encodes a thyroid hormone receptor. Nature 324:641-646.
3. Williams GR, Brent GA 1995 Thyroid hormone response elements. In: Weintraub BD (ed) Molecular Endocrinology: Basic Concepts and Clinical Correlations. Raven Press, Ltd., New York, pp. 217-239.
4. Lazar MA 1993 Thyroid hormone receptors: Multiple forms, multiple possibilities. Endocr Rev 14:184-193.
5. Ribeiro RCJ, Kushner PJ, Baxter JD 1995 The nuclear hormone receptor gene superfamily. Annu Rev Med 46: 443-453.
6. Wurtz J, Bourguet W, Renaud J, Vivat V, Chambon P, Moras D, Gronemeyer H 1996 A canonical structure for the ligand-binding domain of nuclear receptors. Nat Struct Biol 3:87-94.
7. Yu VC, Delsert C, Andersen B, Holloway JM, Devary OV, Naar AM, Kirn SY, Boutin JM, Glass CK, Rosenfeld MG 1991 RXRjS-A coregulator that enhances binding of retinoic acid, thyroid hormone, and vitamin D receptors to their cognate response elements. Cell 67:1251-1266.
8. Kliewer SA, Umesono K, Mangelsdorf DJ, Evans RM 1992 Retinoid X receptor interacts with nuclear receptors in retinoic acid, thyroid hormone and vitamin D3 signalling. Nature 355:446-449.
9. Leid M, Kastner P, Lyons R, Nakshatri H, Saunders M, Zacharewski T, Chen JY, Staub A, Garnier JM, Mader S, Chambon P 1992 Purification, cloning, and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently. Cell 68:377-395.
10. Mitsuhashi T, Tennyson GE, Nikodem VM 1988 Nucleotide sequence of novel cDNAs generated by alternative splicing of a rat thyroid hormone receptor gene transcript. Nucl Acids Res 16:5697.
11. Lazar MA, Hodin RA, Darling DS, Chin WW 1988 Identification of a rat c-erbAα-related protein which binds deoxyribonucleic acid but does not bind thyroid hormone. Mol Endocrinol 2:893-901.
12. Koenig RJ, Lazar MA, Hodin RA, Brent GA, Larsen PR, Chin WW, Moore DD 1989 Inhibition of thyroid hormone action by a non-hormone binding c-erbA protein generated by alternative mRNA splicing. Nature 337:659-661.
13. Miyamoto T, Suzuki S, DeGroot LJ 1993 High affinity and specificity of dimeric binding of thyroid hormone receptors to DNA and their ligand-dependent dissociation. Mol Endocrinol 7:224-231.
14. Yen PM, Darling DS, Carter RL, Forgione M, Umeda PK, Chin WW 1992 Triiodothyronine (T3) decreases binding to DNA by T3-receptor homodimers but not receptor-auxil-iary protein heterodimers. J Biol Chem 267:3565-3568.
15. Olson DP, Koenig RJ 1997 5′ Flanking sequences in thyroid hormone response element half sites determine the requirement of RXR for receptor mediated gene expression. J Biol Chem 272:9907-9914.
16. Katz RW, Koenig RJ 1994 Specificity and mechanism of thyroid hormone induction from an octamer response element. J Biol Chem 269:18915-18920.
17. Toyoda N, Zavacki AM, Maia AL, Harney JW, Larsen PR 1995 A novel retinoid X receptor-independent thyroid hormone response element is present in the human type 1 deiodinase gene. Mol Cell Biol 15:5100-5112.
18. Graf T, Beug H 1978 Avian leukemia viruses: Interaction with their target cells in vivo and in vitro. Biochim Biophys Acta 516:269-299.
19. Vennstrom B, Beug H, Damm K, Engel D, Gehring U, Graf T, Munoz A, Sap J, Zenke M 1987 Biological effects of the v-erbA oncogene in transformation of avian erythroid cells. In: Loos U, Wartofsky L (eds) Molecular Biological Approaches to Thyroid Research. Thieme Medical Publishers, New York, pp. 14-19.
20. Boucher P, Koning A, Privalsky ML 1988 The avian erythroblastosis virus erbA. oncogene encodes a DNA-binding protein exhibiting distinct nuclear and cytoplasmic subcellular localizations. J Virol 62:534-544.
21. Sap J, Munoz A, Schmitt J, Stunnenberg H, Vennstrom B 1989 Repression of transcription mediated at a thyroid hormone response element by the v-erbA oncogene product. Nature 340:242-244.
22. Zenke M, Munoz A, Sap J, Vennstrom B, Beug H 1990 v-erbA. oncogene activation entails the loss of hormone-dependent regulator activity of c-erbA. Cell 61:1035-1049.
23. Danielian PS, White R, Lees JA, Parker MG 1992 Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors. EMBO J 11:1025-1033.
24. Barettino D, Ruiz MDM, Stunnenberg HG 1994 Characterization of the ligand-dependent transactivation domain of thyroid hormone receptor. EMBO J 13:3039-3049.
25. Zhang X, Jeyakumar M, Bagchi MK 1996 Ligand-dependent cross-talk between steroid and thyroid hormone receptors-Evidence for common transcriptional coactivator(s). J Biol Chem 271:14825-14833.
26. Wagner RL, Apriletti JW, McGrath ME, West BL, Baxter JD, Fletterick RJ 1995 A structural role for hormone in the thyroid hormone receptor. Nature 378:690-697.
27. Bourguet W, Ruff M, Chambon P, Gronemeyer H, Moras D 1995 Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-alpha. Nature 375:377-360.
28. Brzozowski AM, Pike ACW, Dauter Z, Hubbard RE, Bonn T, Engström O, Öhman L, Greene GL, Gustafsson J̊, Carlquist M 1997 Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 389:753-758.
29. Halachmi S, Marden E, Martin G, MacKay H, Abbondanza C, Brown M 1994 Estrogen receptor-associated proteins: Possible mediators of hormone-induced transcription. Science 264:1455-1458.
30. Onate SA, Tsai SY, Tsai M-J, O'Malley BW 1995 Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 270:1354-1357.
31. Takeshita A, Yen PM, Misiti S, Cardona GR, Liu Y, Chin WW 1996 Molecular cloning and properties of a full-length putative thyroid hormone receptor coactivator. Endocrinology 137:3594-3597.
32. Hong H, Kohli K, Trivedi A, Johnson DL, Stallcup MR 1996 GRIP1, a novel mouse protein that serves as a transcriptional coactivator in yeast for the hormone binding domains of steroid receptors. Proc Natl Acad Sci USA 93:4948-4952.
33. Voegel JJ, Heine MJS, Zechel C, Chambon P, Gronemeyer H 1996 TIF2, a 160 kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors. EMBO J 15:3667-3675.
34. Anzick SL, Kononen J, Walker RL, Azorsa DO, Tanner MM, Guan XY, Sauter G, Kallioniemi OP, Trent JM, Meltzer PS 1997 AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science 277:965-968.
35. Torchia J, Rose DW, Inostroza J, Kamei Y, Westin S, Glass CK, Rosenfeld MG 1997 The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function. Nature 387:677-684.
36. Chen HW, Lin RJ, Schiltz RL, Chakravarti D, Nash A, Nagy L, Privalsky ML, Nakatani Y, Evans RM 1997 Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300. Cell 90:569-580.
37. Takeshita A, Cardona GR, Koibuchi N, Suen CS, Chin WW 1997 TRAM-1, a novel 160-kDa thyroid hormone receptor activator molecular, exhibits distinct properties from steroid receptor coactivator-1. J Biol Chem 272:27629-27634.
38. Li H, Gomes PJ, Chen JD 1997 RAC3, a steroid/nuclear receptor-associated coactivator that is related to SRC-1 and TIF2. Proc Nad Acad Sci USA 94:8479-8484.
39. Kalkhoven E, Valentine JE, Heery DM, Parker MG 1998 Isoforms of steroid receptor co-activator 1 differ in their ability to potentiate transcription by the oestrogen receptor. EMBO J 17:232-243.
40. Hayashi Y, Ohmori S, Ito T, Seo H 1997 A splicing variant of Steroid Receptor Coactivator-1 (SRC-1E): The major isoform of SRC-1 to mediate thyroid hormone action. Biochem Biophys Res Commun 236:83-87.
41. Heery DM, Kalkhoven E, Hoare S, Parker MG 1997 A signature motif in transcriptional co-activators mediates binding to nuclear receptor. Nature 387:733-736.
42. Lee JW, Choi H-S, Gyuris J, Brent R, Moore DD 1995 Two classes of proteins dependent on either the presence or absence of thyroid hormone for interaction with the thyroid hormone receptor. Mol Endocrinol 9:243-254.
43. Chrivia JC, Kwok RPS, Lamb N, Hagiwara M, Montminy MR, Goodman RH 1993 Phosphorylated CREB binds specifically to the nuclear protein CBP. Nature 365: 855-859.
44. Chakravarti D, LaMorte VJ, Nelson MC, Nakajima T, Schulman IG, Juguilon H, Montminy M, Evans RM 1996 Role of CBP/P300 in nuclear receptor signalling. Nature 383:99-103.
45. Spencer TE, Jenster G, Burcin MM, Allis CD, Zhou JX, Mizzen CA, McKenna NJ, Onate SA, Tsai SY, Tsai M-J, O'Malley BW 1997 Steroid receptor coactivator-1 is a histone acetyltransferase. Nature 389:194-198.
46. Korzus E, Torchia J, Rose DW, Xu L, Kurokawa R, Mc-Inerney EM, Müllen TM, Glass CK, Rosenfeld MG 1988 Transcription factor-specific requirements for coactivators and their acetyltransferase functions. Science 279:703-707.
47. Bhattacharya S, Eckner R, Grossman S, Oldread E, Arany Z, D'Andrea A, Livingston DM 1996 Cooperation of Stat2 and p300/CBP in signaling induced by interferon-alpha. Nature 383:344-347.
48. Horvai AE, Xu L, Korzus E, Brard G, Kalafus D, Mullen TM, Rose DW, Rosenfeld MG, Glass CK 1997 Nuclear integration of JAK/STAT and Ras/AP-1 signaling by CBP and p300. Proc Natl Acad Sci USA 99:1074-1079.
49. Perkins ND, Felzien LK, Betts JC, Leung K, Beach DH, Nabel GJ 1997 Regulation of NF-KB by cyclin-dependent kinases associated with the p300 coactivator. Science 275:523-527.
50. Arias J, Alberts AS, Brindie P, Claret FX, Smeal T, Karin M, Feramisco J, Montminy M 1994 Activation of cAMP and mitogen responsive genes relies on a common nuclear factor. Nature 370:226-229.
51. Petrij F, Giles RH, Dauwerse HG, Saris JJ, Hennekam RCM, Masuno M, Tommerup N, van Ommen GB, Goodman RH, Peters DJM, Breuning MH 1995 Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP. Nature 376:348-351.
52. Rubinstein JH 1990 Broad thumb-hallux (Rubinstein-Taybi) syndrome 1957-1988. Am J Med Genet Suppl 6:3-16.
53. Brucker-Davis F, Skarulis MC, Grace MB, Benichou J, Hauser P, Wiggs E, Weintraub BD 1995 Genetic and clinical features of 42 kindreds with resistance to thyroid hor-mone-The National Institutes of Health Prospective Study. Ann Intern Med 123:572-583.
54. Olson DP, Koenig RJ 1997 Thyroid function in Rubinstein-Taybi syndrome. J Clin Endocrinol Metab 82:3264-3266.
55. Le Douarin B, Zechel C, Garnier J-M, Lutz Y, Tora L, Pierrat B, Heery D, Gronemeyer H, Chambon P, Losson R 1995 The N-terminal part of TIF1, a putative mediator of the ligand-dependent activation function (AF-2) of nuclear receptors, is fused to B-raf in the oncogenic protein T18. EMBO J 14:2020-2033.
56. vom Baur E, Zechel C, Heery D, Heine MJS, Gamier JM, Vivat V, Le Douarin B, Gronemeyer H, Chambon P, Losson R 1996 Differential ligand-dependent interactions between the AF-2 activating domain of nuclear receptors and the putative transcriptional intermediary factors mSUGl and TIF1. EMBO J 15:110-124.
57. Monden T, Wondisford EE, Hollenberg AN 1997 Isolation and characterization of a novel ligand-dependent thyroid hormone receptor-coactivating protein. J Biol Chem 272:29834-29841.
58. Chang KH, Chen YM, Chen TT, Chou WH, Chen PL, Ma YY, Yang-Feng TL, Leng XH, Tsai M-J, O'Malley BW, Lee WH 1997 A thyroid hormone receptor coactivator negatively regulated by the retinoblastoma protein. Proc Natl Acad Sci USA 94:9040-9045.
59. Yang X, Ogryzko W, Nishikawa J, Howard BH, Nakatani Y 1996 A p300/CBP-associated factor that competes with the adenoviral oncoprotein El A. Nature 382:319-324.
60. Puigserver P, Wu Z, Park CW, Graves R, Wright M, Spiegelman BM 1998 A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 92:829-839.
61. Petty KJ, Krimkevich YI, Thomas D 1996 A TATA binding protein-associated factor functions as a coactivator for thyroid hormone receptors. Mol Endocrinol 10:1632-1645.
62. Xu J, Qiu Y, DeMayo FJ, Tsai SY, Tsai M-J, O'Malley BW 1998 Partial hormone resistance in mice with disruption of the steroid receptor coactivator-1 (SRC-1) gene. Science 279:1922-1925.
63. Walfish PG, Yoganathan T, Yang YF, Hong H, Butt TR, Stallcup MR 1997 Yeast hormone response element assays detect and characterize GRIP1 coactivator-dependent activation of transcription by thyroid and retinoid nuclear receptors. Proc Natl Acad Sci USA 94:3697-3702.
64. Bannister AJ, Kouzarides T 1996 The CBP co-activator is a histone acetyltransferase. Nature 384:641-643.
65. Ogryzko W, Schlitz RL, Russanova V, Howard BH, Nakatani Y 1996 The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 87:953-959.
66. Gu W, Roeder RG 1997 Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 90:959-606.
67. Puri PL, Sartorelli V, Yang X, Hamamori Y, Ogryzko VV, Howard BH, Kedes L, Wang JYJ, Graessmann A, Nakatani Y, Levrero M 1997 Differential roles of p300 and PCAF acetyltransferases in muscle differentiation. Mol Cell 1:35-45.
68. Brent GA, Dunn MK, Harney JW, Gulick T, Larsen PR, Moore DD 1989 Thyroid hormone aporeceptor represses T3-inducible promoters and blocks activity of the retinoic acid receptor. New Biol 1:329-336.
69. Baniahmad A, Kohne AC, Renkawitz R 1992 A transferable silencing domain is present in the thyroid hormone receptor, in the v-erbA oncogene product and in the retinoic acid receptor. EMBO J 11:1015-1023.
70. Tong GX, Jeyakumar M, Tanen MR, Bagchi MK 1996 Transcriptional silencing by unliganded thyroid hormone receptor beta requires a soluble corepressor that interacts with the ligand-binding domain of the receptor. Mol Cell Biol 16:1909-1920.
71. Casanova J, Helmer E, Selmi-Ruby S, Qi J-S, Au-Fliegner M, Desai-Yajnik V, Koudinova N, Yarm F, Raaka BM, Samuels HH 1994 Functional evidence for ligand-dependent dissociation of thyroid hormone and retinoic acid receptors from an inhibitory cellular factor. Mol Cell Biol 14: 5756-5765.
72. Metz T, Graf T 1992 The nuclear oncogenes v-erbA and v-ets cooperate in the induction of avian erythroleukemia. Oncogene 7:597-605.
73. Rastinejad F, Perlmann T, Evans RM, Sigler PB 1995 Structural determinants of nuclear receptor assembly on DNA direct repeats. Nature 375:203-211.
74. Hörlein AJ, Näär AM, Heinzel T, Torchia J, Gloss B, Kurokawa R, Ryan A, Kamei Y, Söderström M, Glass CK, Rosenfeld MG 1995 Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature 377:397-404.
75. Chen JD, Evans RM 1995 A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature 377:454-457.
76. Sande S, Privalsky ML 1996 Identification of TRACs (T3 receptor-associating cofactors), a family of cofactors that associate with, and modulate the activity of, nuclear hormone receptors. Mol Endocrinol 10:813-825.
77. Nawaz Z, Tsai M-J, O'Malley BW 1995 Specific mutations in the ligand binding domain selectively abolish the silencing function of human thyroid hormone receptor β. Proc Nad Acad Sci USA 92:11691-11695.
78. Zamir I, Zhang JS, Lazar MA 1997 Stoichiometric and steric principles governing repression by nuclear hormone receptor. Genes Dev 11:835-846.
79. Forman BM, Samuels HH 1990 Interactions among a subfamily of nuclear hormone receptors: The regulatory zipper model. Mol Endocrinol 4:1293-1301.
80. Qi J-S, Desai-Yajnik V, Greene ME, Raaka BM, Samuels HH 1995 The ligand-binding domains of the thyroid hormone/retinoid receptor gene subfamily function in vivo to mediate heterodimerization, gene silencing, and transactivation. Mol Cell Biol 15:1817-1825.
81. Perlmann T, Umesono K, Rangarajan PN, Forman BM, Evans RM 1996 Two distinct dimerization interfaces differentially modulate target gene specificity of nuclear hormone receptors. Mol Endocrinol 10:958-966.
82. Zhang JS, Zamir I, Lazar MA 1997 Differential recognition of liganded and unliganded thyroid hormone receptor by retinoid X receptor regulates transcriptional repression. Mol Cell Biol 17:6887-6897.
83. Olson DP, Sun BL, Koenig RJ 1998 Thyroid hormone response element architecture affects corepressor release from thyroid hormone receptor dimers. J Biol Chem 273: 3375-3380.
84. Nagaya T, Madison L, Jameson JL 1992 Thyroid hormone receptor mutants that cause resistance to thyroid hormone. Evidence for receptor competition for DNA sequences in target genes. J Biol Chem 267:13014-13019.
85. Nagaya T, Jameson JL 1993 Thyroid hormone receptor dimerization is required for dominant negative inhibition by mutations that cause thyroid hormone resistance. J Biol Chem 268:15766-15771.
86. Yoh SM, Chatterjee VKK, Privalsky ML 1997 Thyroid hormone resistance syndrome manifests as an aberrant interaction between mutant T3 receptors and transcriptional corepressors. Mol Endocrinol 11:470-480.
87. Tagami T, Jameson JL 1988 Nuclear corepressors enhance the dominant negative activity of mutant receptors that cause resistance to thyroid hormone. Endocrinology 139: 640-650.
88. Jackson TA, Richer JK, Bain DL, Takimoto GS, Tung L, Horwitz KB 1997 The partial agonist activity of antagonist-occupied steroid receptors is controlled by a novel hinge domain-binding coactivator L7/SPA and the corepressors NCoR or SMRT. Mol Endocrinol 11:693-705.
89. Smith CL, Nawaz Z, O'Malley BW 1997 Coactivator and corepressor regulation of the agonist/antagonist activity of the mixed antiestrogen, 4-hydroxytamoxifen. Mol Endocrinol 11:657-666.
90. Hong SH, David G, Wong CW, Dejean A, Privalsky ML 1997 SMRT corepressor interacts with PLZF and with the PML-retinoic acid receptor alpha (RARα) and PLZF-RARα oncoproteins associated with acute promyelocytic leukemia. Proc Natl Acad Sci USA 94:9028-9033.
91. Grignani F, De Matteis S, Nervi C, Tomassoni L, Gelmetti V, Cioce M, Fanelli M, Ruthardt M, Ferrara FF, Zamir I, Seiser C, Grignani F, Lazar MA, Minucci S, Pelicci PG 1988 Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia. Nature 391:815-818.
92. Lin RJ, Nagy L, Inoue S, Shao WL, Miller WH Jr, Evans RM 1998 Role of the histone deacetylase complex in acute promyelocytic leukaemia. Nature 391:811-814.
93. Yang Y, Burgos-Trinidad M, Wu Y, Koenig RJ 1996 Thyroid hormone receptor variant alpha 2: Role of the ninth heptad in DNA binding, heterodimerization with retinoid X receptors and dominant negative activity. J Biol Chem 271:28235-28242.
94. Zamir I, Dawson J, Lavinsky RM, Glass CK, Rosenfeld MG, Lazar MA 1997 Cloning and characterization of a corepressor and potential component of the nuclear hormone receptor repression complex. Proc Natl Acad Sci USA 94: 14400-14405.
95. Heinzel T, Lavinsky RM, Mullen TM, Soderstrom M, Laherty CD, Torchia J, Yang WM, Brard G, Ngo SD, Davie JR, Seto E, Eisenman RN, Rose DW, Glass CK, Rosenfeld MG 1997 A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression. Nature 387:43-48.
96. Alland L, Muhle R, Hou HJ, Potes J, Chin L, Schreiber-Agus N, DePinho RA 1997 Role for N-CoR and histone deacetylase in Sin3-mediated transcriptional repression. Nature 387:49-55.
97. Wolffe AP 1997 Transcriptional control-Sinful repression. Nature 387:16-17.
98. Pazin MJ, Kadonaga JT 1997 What's up and down with histone deacetylation and transcription? Cell 89:325-328.
99. Hassig CA, Fleischer TC, Billin AN, Schreiber SL, Ayer DE 1997 Histone deacetylase activity is required for full transcriptional repression by mSin3A. Cell 89:341-347.
100. Laherty CD, Yang WM, Sun JM, Davie JR, Seto E, Eisenman RN 1997 Histone deacetylases associated with the mSin3 corepressor mediate Mad transcriptional repression. Cell 89:349-356.
101. Zhang Y, Iratni R, Erdjument-Bromage H, Tempst P, Reinberg D 1997 Histone deacetylases and SAP18, a novel polypeptide, are components of a human Sin3 complex. Cell 89:357-364.
102. Nagy L, Kao HY, Chakravarti D, Lin RJ, Hassig CA, Ayer DE, Schreiber SL, Evans RM 1997 Nuclear receptor repression mediated by a complex containing SMRT, mSinSA, and histone deacetylase. Cell 89:373-380.
103. Wong JM, Patterton D, Imhof A, Guschin D, Shi YB, Wolffe AP 1998 Distinct requirements for chromatin assembly in transcriptional repression by thyroid hormone receptor and histone deacetylase. EMBO J 17:520-534.
104. Hodin RA, Lazar MA, Wintman BI, Darling DS, Koenig RJ, Larsen PR, Moore DD, Chin WW 1989 Identification of a thyroid hormone receptor that is pituitary specific. Science 244:76-79.
105. Prost E, Koenig RJ, Moore DD, Larsen RR, Whalen RG 1988 Multiple sequences encoding potential thyroid hormone receptors isolated from mouse skeletal muscle cDNA libraries. Nucl Acids Res 16:6248.